% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{Leiter:284777, author = {U. Leiter and M. V. Heppt and T. Steeb and M. Alter and T. Amaral and A. Bauer and F. G. Bechara and J. Becker$^*$ and E. W. Breitbart and H. Breuninger and T. Diepgen and T. Dirschka and T. Eigentler and A. K. S. ElGammal and M. Felcht and M. J. Flaig and M. Follmann and K. Fritz and S. Grabbe and R. Greinert and R. Gutzmer and A. Hauschild and U. Hillen and S. Ihrler and S. M. John and L. Kofler and O. Koelbl and A. Krause-Bergmann and K. Kraywinkel and S. Krohn and T. Langer and C. Loquai and C. R. Löser and P. Mohr and D. Nashan and M. Nothacker and C. Pfannenberg and C. Salavastru and L. Schmitz and E. Stockfleth and R.-M. Szeimies and C. Ulrich and S. Voelter-Mahlknecht and D. Vordermark and M. Weichenthal and J. Welzel and K. Wermker and S. Wiegand and C. Garbe and C. Berking}, title = {{S}3 guideline 'actinic keratosis and cutaneous squamous cell carcinoma' - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (c{SCC}), surveillance and prevention.}, journal = {Journal der Deutschen Dermatologischen Gesellschaft}, volume = {21}, number = {11}, issn = {1610-0379}, address = {Berlin}, publisher = {Wiley-Blackwell}, reportid = {DKFZ-2023-02088}, pages = {1422-1434}, year = {2023}, note = {2023 Nov;21(11):1422-1434 / doi: $10.1111/ddg.15256_g$ / PMID: 37946644}, abstract = {Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline 'actinic keratosis and cutaneous squamous cell carcinoma' was updated and expanded by the topics cutaneous squamous cell carcinoma in situ (Bowen's disease) and actinic cheilitis. The guideline is aimed at dermatologists, general practitioners, ear nose and throat specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings, as well as other medical specialties, policy makers and insurance funds involved in the diagnosis and treatment of patients with AK and cSCC. A separate guideline exists for patients and their relatives. In this part, we will address aspects relating to epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.}, cin = {ED01}, ddc = {610}, cid = {I:(DE-He78)ED01-20160331}, pnm = {899 - ohne Topic (POF4-899)}, pid = {G:(DE-HGF)POF4-899}, typ = {PUB:(DE-HGF)16}, pubmed = {pmid:37840404}, doi = {10.1111/ddg.15256}, url = {https://inrepo02.dkfz.de/record/284777}, }